Evidence map›Paper›PMID 42760389›Full record

ReviewNature reviews. Nephrology2026

Megalin: from structure to function.

Elynna B Youm, Andrew Beenken, Ora A Weisz

Abstract readReview
PubMed Publisher
In one paragraph

Review in Nature reviews. Nephrology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Elynna B YoumRenal-Electrolyte Division, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.ORCID http://orcid.org/0000-0003-0219-0429
Andrew BeenkenDivision of Nephrology, Columbia University Vagelos College of Physicians and Surgeons, New York, NY, USA.ORCID http://orcid.org/0000-0003-1166-6716
Ora A WeiszRenal-Electrolyte Division, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. weisz@pitt.edu.ORCID http://orcid.org/0000-0003-2985-4870

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The proximal tubule maintains a robust endocytic pathway that is necessary for the recovery of proteins and vitamins from the ultrafiltrate and for the rapid regulation of ion transport. The large multiligand receptor megalin is essential to this process. In the absence of functional megalin, membrane and fluid flux through endocytic compartments is profoundly compromised, whereas the binding of filtered drugs to megalin is a major cause of nephrotoxicity. Insights into the structure of megalin offers clues as to how megalin might drive endocytic dynamics through pH-dependent conformational rearrangements, and findings from focused ion beam-scanning electron microscopy and machine learning-assisted segmentation challenge the traditional model of proximal tubule endocytosis and instead support a model in which a continuous network of dense apical tubules, together with the endoplasmic reticulum, regulates the control of ligand passage, fission and dissociation. In addition to its function as an endocytic receptor, megalin maintains proximal tubule function through other mechanisms. Genomic analyses and animal studies show that predicted alterations in megalin expression have complex effects on disease progression and protection. Consistent with these observations, megalin expression affects proximal tubule transcription and cell metabolism, with important consequences for disease pathology.

Identifiers

PMID42760389

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.